Microcap Cognition Therapeutics (NASDAQ:CGTX) has skyrocketed 35% in Thursday trading after stating the company had a ...

Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright has ...

The arrival of agentic AI at Goldman Sachs, in which programs don’t just help with tasks but execute complex jobs, signals a ...

A new longitudinal study suggests that overall well-being—and especially a strong sense of purpose—are important components ...

Cognition Therapeutics Inc. (NASDAQ:CGTX) saw its stock climb sharply by 75% following a productive end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) concerning its Alzheimer’s ...

Goldman Sachs ' fondness for technology expands with their latest testing of "Devin," the AI coding agent from Cognition which went viral last year because of its capabilities as well as its ...

Cognition Therapeutics shares surged after the clinical-stage company said it completed the end-of-Phase 2 meeting with the Food and Drug Administration for its zervimesine drug. Shares were up 30% at ...

Turning a childhood curiosity into cutting-edge research, Richmond explores animal behavior and cognition in natural ...

The AI software engineer making its debut on Wall Street was created by Cognition, a startup founded in 2023 and backed by ...

To better understand human cognition, scientists trained a large language model on 10 million psychology experiment questions ...

The brain creates the mind through flexible networks. While science maps this connection, significant questions remain, ...

"The macaques are very visual animals. Their eyesight is similar to that of humans and they are very interested in watching ...